# Arvid Carlsson

> Swedish neuroscientist

**Wikidata**: [Q298045](https://www.wikidata.org/wiki/Q298045)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Arvid_Carlsson)  
**Source**: https://4ort.xyz/entity/arvid-carlsson

## Summary

Arvid Carlsson was a Swedish neuroscientist, pharmacologist, and physician who received the Nobel Prize in Physiology or Medicine in 2000 for his discovery of dopamine as a neurotransmitter and its role in motor control. His groundbreaking research fundamentally changed the understanding of brain chemistry and led to the development of L-DOPA as an effective treatment for Parkinson's disease, transforming the lives of millions of patients worldwide. Carlsson was affiliated with Lund University and the University of Gothenburg throughout his career and received numerous prestigious international awards recognizing his contributions to neuroscience and pharmacology.

## Biography

- **Born**: January 25, 1923 (Sweden)
- **Died**: June 29, 2018
- **Nationality**: Swedish
- **Education**: Degree from Lund University
- **Known for**: Discovery of dopamine as a neurotransmitter and development of L-DOPA treatment for Parkinson's disease
- **Employer(s)**: Lund University, University of Gothenburg
- **Field(s)**: Neuroscience, Pharmacology, Molecular Biology, Chemistry

## Contributions

Arvid Carlsson's most significant scientific contribution was his discovery that dopamine functions as a neurotransmitter in the brain, rather than merely being a precursor to norepinephrine as previously believed. In the late 1950s, through his research at Lund University, he demonstrated that dopamine plays a critical role in regulating motor function and that administering L-DOPA (a precursor to dopamine) could restore motor function in animals with induced parkinsonism. This discovery directly led to the clinical development of L-DOPA as the first effective treatment for Parkinson's disease, which remains the cornerstone of therapy for this debilitating neurological disorder today.

Beyond his dopamine research, Carlsson made important contributions to understanding the mechanisms of neurotransmission, synaptic plasticity, and the pharmacological basis of psychiatric medications. His work on catecholamine metabolism and receptor pharmacology influenced the development of numerous psychotropic drugs used in clinical practice.

## FAQs

**What was Arvid Carlsson's most important scientific discovery?**
Arvid Carlsson's most important discovery was identifying dopamine as an independent neurotransmitter in the brain, rather than simply a biochemical precursor to other catecholamines. This finding, made in the late 1950s, revolutionized neuroscience and led directly to the development of L-DOPA therapy for Parkinson's disease.

**Where did Arvid Carlsson conduct his research?**
Carlsson conducted his research primarily at Lund University and later at the University of Gothenburg, both in Sweden. He served as a professor and researcher at these institutions throughout his academic career.

**What awards did Arvid Carlsson receive?**
Carlsson received numerous prestigious awards including the Nobel Prize in Physiology or Medicine (2000), Wolf Prize in Medicine, Canada Gairdner International Award, Japan Prize, and the Feltrinelli Prize, among many others recognizing his contributions to neuroscience and pharmacology.

**How did Arvid Carlsson's work impact Parkinson's disease treatment?**
Carlsson's discovery that dopamine deficiency causes Parkinson's disease symptoms and that administering L-DOPA can restore motor function transformed Parkinson's disease from a poorly understood and untreatable condition into one that can be effectively managed, significantly improving quality of life for millions of patients worldwide.

**Was Arvid Carlsson affiliated with any academic societies?**
Yes, Carlsson was a member of the Royal Swedish Academy of Sciences (Sweden's national academy of sciences, founded in 1739) and Academia Europaea (the pan-European academy founded in 1988).

## Why They Matter

Arvid Carlsson's work fundamentally transformed the understanding of brain function and neurological disease. His identification of dopamine as a neurotransmitter established a new paradigm in neuroscience and paved the way for understanding how chemical messengers in the brain regulate everything from movement to mood. The clinical application of his research—L-DOPA therapy—has provided effective treatment for Parkinson's disease patients for over five decades, making one of the most common neurodegenerative disorders treatable for the first time in medical history.

His research also laid the groundwork for understanding the biochemical basis of psychiatric disorders and influenced the development of antipsychotic medications and other psychotropic drugs. Without Carlsson's pioneering work, the field of neuropharmacology would have developed along a fundamentally different trajectory, and countless patients would not have access to treatments that are now considered standard of care.

## Notable For

- Nobel Prize in Physiology or Medicine (2000) for discovering dopamine as a neurotransmitter
- Development of L-DOPA therapy for Parkinson's disease
- Member of the Royal Swedish Academy of Sciences
- Member of Academia Europaea
- Recipient of the Wolf Prize in Medicine
- Recipient of the Canada Gairdner International Award
- Recipient of the Japan Prize
- Pioneering research in neuropharmacology and neurotransmission

## Body

### Early Life and Education

Arvid Carlsson was born in Sweden on January 25, 1923. He pursued higher education at Lund University, one of Scandinavia's oldest and most prestigious universities, where he obtained his academic degree. His training in medicine and pharmacology provided him with the interdisciplinary expertise necessary to pursue his groundbreaking research in neuroscience.

### Academic Career

Carlsson spent much of his academic career at Lund University, where he conducted the research that would ultimately lead to his Nobel Prize. He later held positions at the University of Gothenburg, contributing to Sweden's reputation as a center for excellence in biomedical research. Throughout his career, he served as a university teacher, combining research responsibilities with academic instruction and mentorship of younger scientists.

### Research Contributions

Carlsson's research focused on the biochemistry of brain function, particularly the role of catecholamines (a class of neurotransmitters that includes dopamine, norepinephrine, and epinephrine). In the 1950s, prevailing scientific opinion held that dopamine was merely a biochemical intermediate in the synthesis of norepinephrine. Carlsson's innovative experiments using pharmacological interventions and analytical techniques demonstrated that dopamine had distinct physiological functions and served as a critical signaling molecule in specific brain regions.

His experiments showed that depleting brain dopamine levels in laboratory animals produced symptoms resembling Parkinson's disease, while administering L-DOPA—a compound the brain converts to dopamine—reversed these motor deficits. This elegant demonstration established the causal relationship between dopamine deficiency and Parkinson's disease symptoms, providing a rational basis for therapeutic intervention.

### Awards and Recognition

The magnitude of Carlsson's contributions was recognized with the Nobel Prize in Physiology or Medicine in 2000, which he shared with Paul Greengard and Eric Kandel. Beyond the Nobel Prize, his work was honored with numerous other awards including the Wolf Prize in Medicine (Israel), Canada Gairdner International Award, Japan Prize, Feltrinelli Prize (Italy), and the Golden Kraapelin Medal (Germany). He also received the Björkén Prize from Uppsala University, the Nordic Research Prize, the Robert J. and Claire Pasarow Foundation Award for Distinguished Contributions to Neuropsychiatric Research, the Bristol-Myers Squibb Award for Distinguished Achievement in Neuroscience Research, and the Julius Axelrod Award.

### Professional Affiliations

Carlsson's scientific stature was reflected in his memberships in prestigious academic societies. He was elected to the Royal Swedish Academy of Sciences, Sweden's national academy of sciences established in 1739, which also awards the Nobel Prizes. He was also a member of Academia Europaea, a pan-European academy of humanities, sciences, and arts founded in 1988.

### Legacy

Arvid Carlsson's discovery of dopamine's role as a neurotransmitter and the subsequent development of L-DOPA therapy represents one of the most important translational research successes in neuroscience history. His work demonstrated how basic biochemical research could directly translate into life-changing clinical treatments, establishing a paradigm for modern neuropharmacology. The treatment approach he pioneered remains the gold standard for Parkinson's disease management, providing relief to millions of patients worldwide. His research also influenced the development of antipsychotic medications and deepened understanding of psychiatric conditions, extending his impact beyond movement disorders to encompass the broader field of neuropsychiatry.

## References

1. Integrated Authority File
2. [The Nobel Prize in Physiology or Medicine 2000](http://www.nobelprize.org/nobel_prizes/medicine/laureates/2000/)
3. [The Nobel Prize amounts](https://www.nobelprize.org/nobel_prizes/about/amounts/)
4. [Source](https://wolffund.org.il/arvid-carlsson/)
5. [Arvid Carlsson - Curriculum Vitae. Nobel Foundation](https://www.nobelprize.org/prizes/medicine/2000/carlsson/cv/)
6. [Science Careers. 2013](http://science.sciencemag.org/content/sci/340/6132/local/classified.pdf)
7. [GRANTS AND AWARDS PROGRAM FACT SHEET](http://www.bms.com/documents/foundation/factsh.pdf)
8. [Source](https://www.aspet.org/aspet/meetings-awards/aspet-awards/aspet-scientific-achievement-awards/julius-axelrod-award-in-pharmacology)
9. International Standard Name Identifier
10. Virtual International Authority File
11. CiNii Research
12. www.ae-info.org
13. Find a Grave
14. Encyclopædia Britannica Online
15. Brockhaus Enzyklopädie
16. BnF authorities
17. Croatian Encyclopedia
18. Munzinger Personen
19. [Nobelpristagaren Arvid Carlsson är död](https://sverigesradio.se/sida/artikel.aspx?programid=104&artikel=6989864)
20. [Arvid Carlsson: the 2000 Nobel Laureate in Medicine](https://sahlgrenska.gu.se/english/research/researchers/arvid-carlsson)
21. Freebase Data Dumps. 2013
22. Treccani's Enciclopedia on line
23. LIBRIS. 2012